Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression
Status:
Unknown status
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
60 patients with chronic major depressive disorder according to DSM-IV will be included into
the study. Patients will be randomized to receive an open treatment either with CBASP, a
psychotherapy for chronic depression, or pharmacological treatment with Escitalopram for 28
weeks.